Received Jun 15, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y010184 | — |
No symptomatic events reported; an expired dose was administered to a patient; undergone a previous temperature excursion; This Spontaneous report was received from Other health professional and referred to a/an ( Race Unknown ) ( Ethnicity Unknown) patient of unknown age and gender. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On 01-Jun-2026, the patient started therapy with sterile diluent solution for injection (0.70 mL) (total) (Batch/Lot Number: 2053190) (Expiration date: 12-Mar-2028) (Dose Text: 0.7ml). On 01-Jun-2026, the patient started therapy with Varicella Virus Vaccine Live (Oka-Merck) powder and solvent for solution for injection (0.50 mL) (total) (Batch/Lot Number: Y010184) (Expiration date: 31-May-2026) (Dose Text: 0.5ml). The patient started therapy with Varicella Virus Vaccine Live (Oka-Merck) powder and solvent for solution for injection for the treatment of prophylaxis, The patient started therapy with sterile diluent solution for injection for the treatment of prophylaxis, On 01-Jun-2026, the patient experienced undergone a previous temperature excursion (Product storage issue). On 01-Jun-2026, the patient experienced an expired dose was administered to a patient (Expired product administered). On an unknown date, the patient experienced No symptomatic events reported (No adverse event). The Outcome of Expired product administered was not provided. The Outcome of Product storage issue was not provided. The Outcome of No adverse event was not provided. The action taken with sterile diluent solution for injection regarding Expired product administered was Not applicable with Not Applicable dechallenge and rechallenge results. The action taken with Varicella Virus Vaccine Live (Oka-Merck) powder and solvent for solution for injection regarding Expired product administered was Not applicable with Not Applicable dechallenge and rechallenge results. Case Assessments: sterile diluent solution for injection regarding No adverse event with Not Applicable dechallenge and rechallenge results. Case Assessments: sterile diluent solution for injection regarding Product storage issue with Not Applicable dechallenge and rechallenge results. Case Assessments: Varicella Virus Vaccine Live (Oka-Merck) powder and solvent for solution for injection regarding No adverse event with Not Applicable dechallenge and rechallenge results. Case Assessments: Varicella Virus Vaccine Live (Oka-Merck) powder and solvent for solution for injection regarding Product storage issue with Not Applicable dechallenge and rechallenge results. The Other health professional considered the event No adverse event (,) to be not assessed to sterile diluent solution for injection, the event Product storage issue (,) to be not assessed to sterile diluent solution for injection, the event No adverse event (,) to be not assessed to Varicella Virus Vaccine Live (Oka-Merck) powder and solvent for solution for injection, the event Product storage issue (,) to be not assessed to Varicella Virus Vaccine Live (Oka-Merck) powder and solvent for solution for injection, the event Expired product administered (,) to be not assessed to sterile diluent solution for injection, and the event Expired product administered (,) to be not assessed to Varicella Virus Vaccine Live (Oka-Merck) powder and solvent for solution for injection The Other health professional considered the event Product storage issue to be non-serious, the event Expired product administered to be non-serious, and the event No adverse event to be non-serious
MERCK STERILE DILUENT